Jacobs Levy Equity Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-6,062
| Closed | -$1.69M | – | 962 |
|
|
2025
Q2 | $1.69M | Sell |
6,062
-222,753
| -97% | -$63.1M | 0.01% | 656 |
|
|
2025
Q1 | $71.3M | Buy |
+228,815
| New | +$67.6M | 0.28% | 86 |
|
|
2023
Q3 | – | Sell |
-26,674
| Closed | -$5.92M | – | 962 |
|
|
2023
Q2 | $5.92M | Sell |
26,674
-13,715
| -34% | -$3.18M | 0.03% | 362 |
|
|
2023
Q1 | $9.76M | Buy |
40,389
+29,873
| +284% | +$7.33M | 0.06% | 288 |
|
|
2022
Q4 | $2.76M | Buy |
+10,516
| New | +$2.82M | 0.02% | 496 |
|
|
2022
Q3 | – | Sell |
-7,969
| Closed | -$1.94M | – | 984 |
|
|
2022
Q2 | $1.94M | Buy |
7,969
+5,389
| +209% | +$1.32M | 0.02% | 604 |
|
|
2022
Q1 | $624K | Buy |
+2,580
| New | +$593K | ﹤0.01% | 830 |
|
|
2019
Q3 | – | Sell |
-84,190
| Closed | -$15.5M | – | 915 |
|
|
2019
Q2 | $15.5M | Buy |
+84,190
| New | +$15.1M | 0.21% | 119 |
|
|
2018
Q4 | – | Sell |
-6,294
| Closed | -$1.3M | – | 973 |
|
|
2018
Q3 | $1.3M | Sell |
6,294
-757
| -11% | -$149K | 0.02% | 601 |
|
|
2018
Q2 | $1.3M | Buy |
7,051
+4,879
| +225% | +$863K | 0.02% | 594 |
|
|
2018
Q1 | $370K | Buy |
+2,172
| New | +$399K | 0.01% | 827 |
|
|
2017
Q3 | – | Sell |
-24,042
| Closed | -$4.14M | – | 945 |
|
|
2017
Q2 | $4.14M | Sell |
24,042
-8,150
| -25% | -$1.33M | 0.09% | 266 |
|
|
2017
Q1 | $5.28M | Sell |
32,192
-247,779
| -89% | -$41.2M | 0.11% | 243 |
|
|
2016
Q4 | $40.9M | Sell |
279,971
-61,583
| -18% | -$9.27M | 0.79% | 12 |
|
|
2016
Q3 | $57M | Buy |
341,554
+17,391
| +5% | +$2.94M | 1.02% | 5 |
|
|
2016
Q2 | $49.3M | Sell |
324,163
-2,707
| -0.8% | -$421K | 1.02% | 5 |
|
|
2016
Q1 | $49M | Sell |
326,870
-43,334
| -12% | -$6.44M | 1.04% | 7 |
|
|
2015
Q4 | $60.1M | Sell |
370,204
-16,740
| -4% | -$2.63M | 1.19% | 5 |
|
|
2015
Q3 | $53.5M | Buy |
386,944
+554
| +0.1% | +$87.3K | 1.1% | 5 |
|
|
2015
Q2 | $59.3M | Sell |
386,390
-84,827
| -18% | -$13.6M | 1.13% | 4 |
|
|
2015
Q1 | $75.3M | Buy |
471,217
+334
| +0.1% | +$52.6K | 1.28% | 3 |
|
|
2014
Q4 | $75M | Sell |
470,883
-53,416
| -10% | -$8.32M | 1.29% | 4 |
|
|
2014
Q3 | $73.6M | Buy |
524,299
+27,710
| +6% | +$3.62M | 1.23% | 7 |
|
|
2014
Q2 | $58.8M | Buy |
496,589
+118,869
| +31% | +$13.8M | 0.97% | 8 |
|
|
2014
Q1 | $46.6M | Sell |
377,720
-137,355
| -27% | -$16.7M | 0.78% | 19 |
|
|
2013
Q4 | $58.8M | Buy |
515,075
+472,657
| +1,114% | +$53.8M | 0.88% | 10 |
|
|
2013
Q3 | $4.75M | Sell |
42,418
-241,802
| -85% | -$26.2M | 0.08% | 290 |
|
|
2013
Q2 | $28M | Buy |
+284,220
| New | +$29.5M | 0.5% | 49 |
|
Other funds holding AMGN
Jacobs Levy Equity Management's AMGN Position: Q3 2025 in Review
Jacobs Levy Equity Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 6,062 shares — an estimated $1.69M sold.
Jacobs Levy Equity Management first reported a position in AMGN in Q2 2013 and held it in 28 quarters. The position peaked at $75.3M in Q1 2015. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Jacobs Levy Equity Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Jacobs Levy Equity Management sold 6,062 Amgen shares in Q3 2025, an estimated $1.69M.
- Jacobs Levy Equity Management first reported a position in Amgen in Q2 2013 and held it in 28 quarters.
- Jacobs Levy Equity Management's Amgen position peaked at $75.3M in Q1 2015.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.